IRAK1 and primary effusion lymphoma: A study focused on primary effusion lymphoma (PEL) reported a missense mutation in IRAK1, resulting in a Phe196Ser substitution that renders IRAK1 constitutively active, marking it as the main driver for Kaposi sarcoma herpesvirus lymphoma [53].